American Conference Institute’s 3rd Annual Conference on: Life Sciences Compliance – Boot Camp
30 January – 1 February 2017
The discussion will focus on:
- Compliance guidelines for participating in Medicare, Medicaid, VA and DoD programs
- Price reporting authorities, programs and vocabulary
- CMS
- Medicaid
- Best Price: AMP
- Medicare: Parts B and D
- ASP
- ASP +6
- CAP
- WAMP
- VA/DOD
- GSA, FSS
- Special pricing and reimbursement compliance concerns for devices
- Devising price reporting strategy assessments
- When and how companies best communicate changes in price reporting methodologies to appropriate authorities
- Red flags that regulators and enforcers look at when investigating price reporting fraud and abuse
- How to best involve your compliance department in price and reporting and reimbursement matters
For more information and to register visit the American Conference website.
People
Related Insights
10 October 2024
Viewpoints
Proposed Rule Targeting Connected Vehicles Will Impose Major New Supply Chain Compliance Requirements on Automotive Companies that Source from Russia or China
On September 26, 2024, the Department of Commerce’s Bureau of Industry and Security (BIS) published a Notice of Proposed Rulemaking that, if finalized, would prohibit the sale or import of certain automotive hardware and software, as well as “connected vehicles” incorporating this technology, from or linked to the People’s Republic of China or Russia.
11 October 2024
Events
Managing Risk and Driving Resilience | Cybersecurity Summit 2024
On Friday, October 11, Foley Partner Jen Urban will speak on the panel titled, “Managing Risk and Driving Resilience.”
10 October 2024
Manufacturing Industry Advisor
Stellantis Files String of Lawsuits Against UAW Claiming Strike Threats Are Bad Faith
On October 7, 2024, in a coordinated attack, Chrysler owner Stellantis filed a string of lawsuits across multiple jurisdictions against the United Auto Workers Union (“UAW”) and numerous local chapters regarding the UAW’s threats to strike if Stellantis does not move forward with planned investments in its U.S. operations.